Loading…
ALC
Alcon Inc
NYSE· Healthcare· Medical Instruments & Supplies· CUSIP H01301128
$70.63+4.75%Price as of Oct 23, 00:47 UTC · updated once a day, after the close
At a glance
Alcon Inc (ALC) is listed on NYSE and classified in Medical Instruments & Supplies, part of the Healthcare sector. It is headquartered in Geneva, Switzerland and has 25,000 employees. The company is worth $34.14B and trades at 51.2x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was $10.4B in fiscal 2025, up 4.9% from the year before. Net income was $980M. The share price is 19.4% below its 52-week high of $87.64. It pays a dividend yielding 0.51%. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Two Sigma (Two Sigma Investments), at $30.5M. In that quarter, 2 of them opened or added to the position and 3 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $34.14B
- P/E
- 51.2x
- Forward P/E
- 17.8x
- P/B
- 1.6x
- Dividend yield
- 0.51%
- Payout
- 26.09%
- EPS
- $1.38
- ROE
- 2.94%
- Profit margin
- 5.92%
- Revenue growth
- +8.70%
- Beta
- 0.73
- 52-week high
- $87.64
- 52-week low
- $61.84
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -15.6% over 5Y.
today you would have $808.11▼ -19.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $78.81 | $84.89 | $78.12 | $68.55 | |
| P/E | 40.6x | 39.8x | 41.4x | 39.9x | 100.8x |
| P/S | 4.0x | 3.7x | 4.2x | 4.1x | 3.9x |
| P/B | 1.8x | 1.7x | 1.9x | 1.9x | 1.7x |
| EPS | $1.98 | $2.05 | $1.96 |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
$37.24
Square root of 22.5 × earnings × book value. Blind to intangibles, so it undervalues software and brands.
Earnings
$35.20
Earnings growing 25.0% a year plus a 0.5% dividend yield. Growth capped at 25%.
Earnings
$33.51
Median P/E of 24.3 among peers in the sector.
Earnings
$56.07
Median P/E of 40.6 across this company’s own years on record.
Cash flow
$111.75
Cash flow growing 15.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
$76.83
Sector median of 14.1x operating profit, less net debt. Banks have no EBITDA.
Dividends
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ZTSZoetis Inc. | $82.00 | 13.5x | 10.8x | 2.59% | 64.91% | $33.88B |
| MTDMettler Toledo International Inc/ | $1,684.64 | 38.0x | 2632.3x | 0.00% | — | $33.75B |
| CNCCentene Corp | $71.24 | — | 1.6x | 0.00% | -20.36% | $35.19B |
| RMDResmed Inc | $253.06 |
About the company
- 25,000
- Geneva, Switzerland